A systematic review of the humanistic, economic, sociodemographic, and environmental burden of severe/difficult-to-treat asthma.

IF 2.4 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Arnaud Bourdin, Ioanna Vlachaki, Alessandra Madoni, Simon Donhauser, Marielle van der Deijl, Mithun Chakrawarthy Manne, Bala Ganesh Geddamuri, Nicola A Hanania
{"title":"A systematic review of the humanistic, economic, sociodemographic, and environmental burden of severe/difficult-to-treat asthma.","authors":"Arnaud Bourdin, Ioanna Vlachaki, Alessandra Madoni, Simon Donhauser, Marielle van der Deijl, Mithun Chakrawarthy Manne, Bala Ganesh Geddamuri, Nicola A Hanania","doi":"10.1080/03007995.2025.2513963","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>We examined gaps in our understanding of the health-related, humanistic, socioeconomic, and environmental burden of patients with difficult-to-treat/severe asthma.</p><p><strong>Methods: </strong>A systematic literature review was performed using Embase and MEDLINE. The searchs were performed separately for studies investigating humanistic and economic burden and those investigating environmental and sociodemographic impact, using a predefined search strategy. Study selection was based on the population, interventions, comparisons, outcomes, and study design framework. Data extraction from full-text publications was conducted using a standardized Microsoft Excel© template.</p><p><strong>Results: </strong>Fifty-two studies reporting the humanistic and economic burden and 11 studies reporting the environmental and sociodemographic impact were identified. Patients with severe vs non-severe asthma had lower quality of life (QoL). As expected, the impact of asthma on healthcare resource utilization and costs increased with disease severity. More frequent hospitalizations, emergency department visits, longer hospital length of stay, and higher frequency of exacerbations were seen in severe vs non-severe asthma. Eleven studies reported on factors such as air pollution and their association with increased risk of asthma severity, and there is a lack of evidence specifically addressing its impact on severe asthma.</p><p><strong>Conclusion: </strong>Severe asthma imposes significant economic and humanistic burdens on patients and healthcare systems. Both environmental and sociodemographic factors exacerbate asthma severity and should be further investigated to ensure optimal asthma management. Gaps remain in our knowledge of the impact of climate change on the most vulnerable patients with severe disease and our review highlights aspects of this burden that are still to be fully understood.</p>","PeriodicalId":10814,"journal":{"name":"Current Medical Research and Opinion","volume":" ","pages":"1-21"},"PeriodicalIF":2.4000,"publicationDate":"2025-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Medical Research and Opinion","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03007995.2025.2513963","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: We examined gaps in our understanding of the health-related, humanistic, socioeconomic, and environmental burden of patients with difficult-to-treat/severe asthma.

Methods: A systematic literature review was performed using Embase and MEDLINE. The searchs were performed separately for studies investigating humanistic and economic burden and those investigating environmental and sociodemographic impact, using a predefined search strategy. Study selection was based on the population, interventions, comparisons, outcomes, and study design framework. Data extraction from full-text publications was conducted using a standardized Microsoft Excel© template.

Results: Fifty-two studies reporting the humanistic and economic burden and 11 studies reporting the environmental and sociodemographic impact were identified. Patients with severe vs non-severe asthma had lower quality of life (QoL). As expected, the impact of asthma on healthcare resource utilization and costs increased with disease severity. More frequent hospitalizations, emergency department visits, longer hospital length of stay, and higher frequency of exacerbations were seen in severe vs non-severe asthma. Eleven studies reported on factors such as air pollution and their association with increased risk of asthma severity, and there is a lack of evidence specifically addressing its impact on severe asthma.

Conclusion: Severe asthma imposes significant economic and humanistic burdens on patients and healthcare systems. Both environmental and sociodemographic factors exacerbate asthma severity and should be further investigated to ensure optimal asthma management. Gaps remain in our knowledge of the impact of climate change on the most vulnerable patients with severe disease and our review highlights aspects of this burden that are still to be fully understood.

对严重/难治性哮喘的人文、经济、社会人口和环境负担的系统回顾。
目的:哮喘发病率高,对生活质量(QoL)有显著影响。我们检查了我们对难以治疗/严重哮喘患者的健康相关、人文、社会经济和环境负担的理解差距。方法:根据《Cochrane干预措施系统评价手册》、评价和传播中心指南原则以及系统评价和meta分析指南的首选报告项目,使用Embase®和MEDLINE®进行系统文献综述。使用预定义的检索策略,分别对人文和经济负担研究和环境和社会人口影响研究进行文献检索。研究选择基于人群、干预措施、比较、结果和研究设计框架。使用标准化的Microsoft Excel©模板从全文出版物中提取数据。结果:确定了52项研究报告了人文和经济负担,11项研究报告了环境和社会人口影响。重度哮喘患者与非重度哮喘患者的生活质量较低。正如预期的那样,哮喘对医疗资源利用和成本的影响随着疾病严重程度的增加而增加。严重哮喘患者比非严重哮喘患者更频繁地住院、急诊、更长的住院时间和更高的发作频率。11项研究报告了空气污染等因素及其与哮喘严重程度风险增加的关联,但缺乏具体证据说明空气污染对严重哮喘的影响。结论:严重哮喘给患者和卫生保健系统带来了巨大的经济和人文负担。环境和社会人口因素都会加剧哮喘的严重程度,应进一步调查以确保最佳的哮喘管理。我们对气候变化对患有严重疾病的最脆弱患者的影响的认识仍然存在差距,我们的审查强调了这一负担的一些方面仍有待充分了解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Medical Research and Opinion
Current Medical Research and Opinion 医学-医学:内科
CiteScore
4.40
自引率
4.30%
发文量
247
审稿时长
3-8 weeks
期刊介绍: Current Medical Research and Opinion is a MEDLINE-indexed, peer-reviewed, international journal for the rapid publication of original research on new and existing drugs and therapies, Phase II-IV studies, and post-marketing investigations. Equivalence, safety and efficacy/effectiveness studies are especially encouraged. Preclinical, Phase I, pharmacoeconomic, outcomes and quality of life studies may also be considered if there is clear clinical relevance
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信